If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 1 - 10 of 20
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Objective
Clinical trial of atrial fibrillation patients comparing left atrial appendage occlusion therapy to non-vitamin K antagonist oral anticoagulants
Protocol No
CVC-ABBOTT-CATALYST
Categories
Impella-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Objective
Impella-Supported PCI in Complex Coronary Artery Disease PROTECT IV
Protocol No
CVC-ABIOMED-PROTECT-IV
Categories
Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
Objective
AccuCinch Ventricular Restoration System in HFrEF
Protocol No
CVC-ANCORA-CORCINCH-HF
Categories
Deliver Insights in Hypertrophic Cardiomyopathy and Observational Outcomes in Real World: United States Prospective Registry Study
Objective
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Protocol No
CVC-BMS-DISCOVER-HCM
Categories
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
Objective
Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
Protocol No
CVC-BOSTONSCIENTIFIC-ACURATE
Categories
A Phase 3, Multi-center, Randomized, Double-blind Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Objective
Aficamten v Placebo in Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Protocol No
CVC-CYTOKINETICS-CY6033
Categories
REACT-AF: Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Objective
REACT-AF Monitoring AFib
Protocol No
CVC-JH-REACT-AF
Categories
Randomized Evaluation of Bromocriptine In Myocardial Recovery THerapy for Peripartum Cardiomyopathy (REBIRTH)
Objective
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
Protocol No
CVC-NHLBI-REBIRTH
Categories
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial
Objective
Revascularization Choices Among under-Represented Groups Evaluation
Protocol No
CVC-PCORI-RECHARGE-M
Categories
Cerebral Protection in Transcatheter Aortic Valve Replacement: The PROTEMBO Trial
Objective
Cerebral Protection in Transcatheter Aortic Valve Replacement
Protocol No
CVC-PROTEMBIS-PROTEMBO
Categories